CLINICAL_TRIALS
withdrawal
· 2011-08-12
Clinical Trial Update: Study of MB07811 in Subjects With Hypercholesterolemia [Phase 2]
Summary
This Phase 2 trial of MB07811 in hypercholesterolemia has been withdrawn.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Ligand Pharmaceuticals | Conditions: Hypercholesterolemia | Phase 2 | Status: WITHDRAWN